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The chick embryo represents an accessible and economical in vivo model, which has long 
been used in developmental biology, gene expression analysis, and loss/gain of function 
experiments. In the present study, we assessed and characterized bone marrow derived 
mesenchymal stem cells from prenatal day 13 chicken embryos (chBMMSCs) and 
determined some novel properties. After assessing the mesenchymal stem cell (MSC) 
properties of these cells by the presence of their signature markers (CD 44, CD 73, CD 90, 
CD 105, and vimentin), we ascertained a very broad spectrum of multipotentiality as these 
MSCs not only differentiated into the classic tri-lineages of MSCs but also into ectodermal, 
endodermal, and mesodermal lineages such as neuron, hepatocyte, islet cell, and cardiac. In 
addition to wide plasticity, we detected the presence of several pluripotent markers such as 
Oct4, Sox2, and Nanog. This is the first study characterizing prenatal chBMMSCs and their 
ability to not only differentiate into mesenchymal lineages but also into all the germ cell layer 
lineages. Furthermore, our studies indicate that prenatal chBMMSCs derived from the chick 
provide an excellent model for multi-lineage development studies because of their broad 
plasticity and faithful reproduction of MSC traits as seen in the human. Here, we also present 
evidence for the first time that media derived from prenatal chBMMSC cultures have an anti-
tumorigenic, anti-migratory, and pro-apoptotic effect on human tumors cells acting through 
the Wnt-ß-catenin pathway. These data confirm that chBMMSCs are enriched with factors in 
their secretome that are able to destroy tumor cells. This suggests a commonality of 
properties of MSCs across species between human and chicken.  
Key words- Mesenchymal stem cells, chicken, pluripotency, tumor suppression, multi-
lineage differentiation 



































































Bone marrow derived mesenchymal stem cells (BMMSCs) can be differentiated into distinct 
skeletal tissues both in vitro and in vivo. Understanding the molecular mechanisms 
controlling stem cell differentiation is imperative for further progress in tissue and organ 
regeneration. The chicken embryo has traditionally been a favorite model of developmental 
biologists and cancer biologists, and has been used a platform to study stem cell implantation 
and differentiation in vivo. Being a versatile animal model, the chicken embryo has been used 
extensively for xenotransplantation studies of human stem cells from multiple sources. 
Human dental pulp stem cells, after transplantation into the mesencephalon region of the 
chicken embryo, expressed neuronal markers and acquired typical neuronal morphology [1]. 
Similarly, human-derived hematopoietic stem cells [2], olfactory mucosa stem cells [3], 
embryonic stem cells [4], and mesenchymal stem cells [5] have been shown to differentiate 
into multiple lineages when transplanted into the chicken embryo. In addition, the chicken 
embryo has also been used to study cell-to-cell interactions between human skin-derived stem 
cells and glioma cells [6]. Thus, the success of using the chicken embryo as an efficient 
xenotransplantation platform for studying human stem cell biology can be attributed to easy 
handling, accessibility to surgical implantation methods, and a lack of an advanced immune 
system. 
Khatri et al. [7] characterized chicken lung mesenchymal stromal cells and studied their 
susceptibility to avian influenza virus. A genetic marker, namely, deleted-in-azoospermia-like 
(DAZL), was conserved in primordial germ cells (PGCs) and during germ-line differentiation 
until the adult stage, making them a valuable molecular marker for studies of PGC 
differentiation and germ-line development in the chicken [8]. However, the earliest MSCs to 


































































comprehensive study of the BMMSCs from chicken embryos has not been performed so far. 
Therefore, in this study we not only profiled the characteristic stem cell features of BMMSCs 
derived from prenatal chicken embryos (chBMMSCs), but also explored their plasticity in 
order to evaluate the plethora of lineages into which stem cells obtained from an early 
developmental stage can transform. We also identified a very interesting property of anti-
tumorigenicity in these chBMMSCs. This study will help in validating chick-derived prenatal 
stem cells as a highly robust and flexible platform for multiple lineage commitment and 
differentiation studies. 
METHODS 
ISOLATION AND EXPANSION OF chBMMSCs 
Chick embryos of 12-13 days (obtained from Veterinary College, Bangalore, India, after 
approval by the Institutional Ethics Committee) were opened from the shell, and bone 
marrow was collected from the femur by flushing with stem cell growth medium containing 
DMEM with high glucose (Gibco) supplemented with 1X GlutaMAX (Life Technologies), 
10% Fetal Bovine Serum (FBS) (Hyclone), and 100U/mL PenStrep (Life Technologies) 
using a sterile syringe. The aspirated bone marrow cells were centrifuged twice at 1500 rpm 
for 10 min in fresh growth medium, and plated at a density of 1 x 10
6
cells/ml. The cultures
were incubated at 37
◦
C in a humidified atmosphere containing 5% CO2. The floating cells
were initially removed at intervals of 12-24h and the cells were characterized for the colony 
forming ability typical of mesenchymal stromal cells. The colony forming units (CFUs) were 
identified by staining with 0.1% crystal violet, and culture medium was changed every day 
until confluence was reached. Expansion of chBMMSCs was performed as previously 
reported for MSCs derived from the human amniotic membrane [9]. Briefly, after reaching 


































































passaged till P4 to obtain a homogenous population. The cells at P3 were characterized 
further and used for subsequent experiments. 
GROWTH CURVE ANALYSIS AND POPULATION DOUBLING TIME 
Chick BMMSCs at p3 were plated at 1000 cells/well in a 96 well plate and a growth curve 
was determined by using an MTT assay (Trevigen) at different time points (1, 2, 3, 4, and 5 
days). From the growth curve, the population doubling time was determined [10]. 
MULTI-LINEAGE DIFFERENTIATION 
At the third passage, chBMMSCs were induced to differentiate into the classic tri-lineage of 
MSCs; namely osteogenic, adipogenic, and chondrogenic, and into the representative 
lineages of the three germ layers; namely neuronal, cardiac, hepatic, and islet cell using 
previously described protocols as follows. 
Adipogenesis induction medium contained 1 μmol/L dexamethasone (Sigma-Aldrich), 10 
μg/ml insulin (Clonetics), and 100 μmol/L indomethacin (Sigma-Aldrich) [11]. Osteogenesis 
induction medium consisted of 0.1 μmol/L dexamethasone (Sigma-Aldrich), 0.2mmol/L 
ascorbic acid (Clonetics), and 10 mmol/L glycerol 2-phosphate (Sigma-Aldrich) [12]. 
Chondrogenesis was induced by 0.2 mmol/L ascorbic acid 2-phosphate solution (Clonetics), 
0.1μmol/L dexamethasone (Sigma-Aldrich), 0.1mmol/L non-essential amino acid (Hi-
Media), and 1mM sodium pyruvate (Sigma-Aldrich) [13]. Within 2-3 days, morphological 
changes into the tri-lineages were observed and adipocytes, osteocytes, and chondrocytes 
were fixed and stained with Oil Red O Solution (0.5%), Von Kossa Solution (2.5%), and 1% 
Alcian Blue solution (all from Sigma-Aldrich) respectively and visualized under a bright field 
phase contrast microscope (Nikon- Eclipse TE 2000-S). Photographs were taken using 


































































Hepatogenic differentiation was performed by treating chBMMSCs with hepatic induction 
medium consisting of 20 ng/mL bFGF (Clonetics), 0.5μM dexamethasone (Sigma-Aldrich), 
and 50 mg/mL insulin transferrin selenium (ITS) (Invitrogen) [14]. Islet differentiation was 
performed according to a reported protocol [15] wherein induction medium consisted of 
10mM nicotinamide (Sigma-Aldrich), 2.5mM mercaptoethanol (Sigma-Aldrich), and 2.5mM 
glucose (Hi-media). Neuronal induction was performed using 10ng/ml bFGF (Clonetics) [16, 
17], 0.5 μM retinoic acid (Sigma-Aldrich), and 1 mM ß-mercaptoethanol (Sigma-Aldrich). 
Cardiac differentiation was achieved using an induction medium containing 10µm 5- 
azacytidine [18]. In all cases, the morphological changes appeared within 3-4 days.  Hepatic 
cells and islets were fixed and stained with 0.5% Periodic acid–Schiff stain (PAS) and 100X 
Dithiazone (DTZ) (Sigma-Aldrich) respectively, and visualized under a bright field phase 
contrast microscope (Nikon- Eclipse TE 2000-S). Neuronal and cardiac cells were fixed for 
immunolocalization using mAbs for Nestin (1:250 dilution) and GATA4 (1:250 dilution) 
(BD Biosciences) respectively. 
IMMUNOCYTOCHEMISTRY 
Cells from passage P3 were grown in 4-chambered slides and fixed using 4% 
paraformaldehyde for 20 min at 4°C, and blocked with 3% bovine serum albumin (BSA) in 
PBS for 30 min at room temperature. The cells were then incubated for 1h in dark conditions 
at 4°C with primary non-labeled mouse anti-human antibodies against vimentin, CD 73, ß-3-
tubulin, insulin receptor, troponin I, GATA4, Oct4, and Sox2 (1:250 dilutions, BD 
Biosciences) followed by anti-mouse rabbit fluorescein isothiocyanate (FITC) or 
phycoerythrin (PE) labeled secondary antibodies (1:250 dilutions, Invitrogen) for 1h at 37°C. 
An additional step was included for staining the intracellular, nuclear, or cytoskeletal markers 


































































the cells with PBS containing 0.05% Tween-20 along with the treatment of cells using 3% 
BSA containing 0.1% Triton X 100 for 30 min at room temperature to ensure that cell 
permeability was achieved. The nuclear stain 4’,6-diamidoino-2-phenylindole (DAPI) 
(1:10000 dilution) was used for nuclear visualization and a drop of anti-fade (Vectashield; 
Vector Laboratory, Burlingame CA, USA) was added to avoid quenching of the 
fluorochrome before placing the cover slip. The slides were visualized using a Nikon Eclipse 
TE2000-U fluorescent microscope and photographs were taken using Qimaging- QICAM-
fast 1394. 
FLOW CYTOMETRY 
Chick BMMSCs at P3 were removed from the culture dish with 0.05% Trypsin- EDTA, the 
cell suspension was centrifuged at 1000 rpm for 10 min and washed twice with PBS. Cells 
were fixed in pre-chilled 70% ethanol and incubated in mouse anti-human FITC labeled 
antibodies against CD73, CD90, and CD34 (1:100 dilution) (all antibodies were purchased 
from Becton Dickenson, San Diego, CA, USA) for 1h on ice. The cells were acquired using 
BD-FACS Calibur flow cytometer with a 488nm laser and data were analyzed by Cell Quest 
Software (Becton Dickinson, San Jose, CA, USA). 
SEMI-QUANTITATIVE REVERSE TRANSCRIPTION-PCR: 
RNA Isolation, cDNA Synthesis, and Quantitative reverse transcription PCR. 
Total RNA was extracted from chBMMSCs and the human primary glioblastoma U87-MG 
cell line using the RNeasy Plus Mini kit (Qiagen) according to the manufacturer’s 
instructions. One microgram of total RNA was reverse-transcribed using SuperScript III 
First-Strand Synthesis System (Invitrogen, Carlsbad, CA). One microgram of total RNA was 


































































DEPC treated water  and heated at 65°C for 10 minutes, followed by incubation on ice. After 
primer hybridisation, 7 μL reaction volume containing 5X first strand buffer, RNase OUT 
(40U/μL), 0.1 M DTT, and Superscript III were added to the RNA and subjected to 
thermocycling (25°C, 5 min; 50°C, 60 min; 70°C, 15 min) in a Veriti 96 well thermal cycler 
(Applied Biosystems). Qualitative expression of chicken-specific mesenchymal stem cell 
markers, lineage differentiation markers, and apoptotic markers (primers from Sigma, 
sequence as indicated in Tables 1 and 2) were analyzed by PCR (95°C 30s; annealing 
temperature, 30s; 72°C 30s for 40 cycles) in a Veriti 96 well thermal cycler. Products were 
separated by 1.5 % agarose gel electrophoresis and detected using ethidium bromide.  
Integrated density values (IDV) were calculated using Alpha manager. 
REAL-TIME QUANTITATIVE REVERSE TRANSCRIPTION-PCR. 
The qualitative results of mRNA expression were further quantified using iQ SYBR Green 
Supermix (Bio-Rad, Hercules, CA) in a real time PCR system. cDNAs and gene-specific 
primers were mixed with 2X iQ SYBR Green Supermix (Bio-Rad), and dispensed on a 
MicroAmp® Optical 8-Tube Strip. Fluorescence shift was observed using a 7500 Real-time 
PCR system (Applied Biosystems). Reaction parameters were 50°C for 2 minutes, 95°C for 
10 minutes, followed by 40 cycles of 95°C for 15 seconds and 60°C for 1 minute. The 
relative abundance of mRNAs was obtained using the comparative cycle threshold method 
and was normalized to the housekeeping control GAPDH. Results are also expressed as fold 




































































The TACS MTT assay kit (R&D Systems) was used according to the manufacturer’s protocol 
to measure cell metabolic viability. Conditioned medium of chBMMSCs (BMMSC-CM) was 
prepared by collecting the medium in which the cells were cultured at P0, P1, P2, and P3, and 
centrifuging at 1500rpm to remove cell debris. The medium was stored at -20°C till use. The 
U87 (U87-MG grade 4 glioblastoma) and Hep2 (Human Larynx carcinoma) cell lines were 
obtained from ATCC and cultured and maintained in DMEM/F-12 (Gibco) (1:1) containing 
1X GlutaMAX (Life Technologies), 10% Fetal Bovine Serum (Hyclone), and 100U/mL 
PenStrep (Life Technologies). Non-stem cell controls used were human fibroblasts and 
mouse embryonic fibroblasts obtained from primary cultures. 10,000 cells per well were 
plated in a flat-bottomed 96-well plate. After 12 hours, they were given a medium change and 
chBMMSC conditioned medium from P0, P1, P2, and P3 was added to the plates and 
incubated for 24h. Following treatment, cells were washed with 1X PBS and provided with 
100uL of fresh basal medium (DMEM/F-12 + DMEM-LG) along with 10uL of MTT. 
Samples were incubated for 3 hours at 37°C and 5% CO2. The dye was solubilized by the 
addition of 100uL detergent reagent and an overnight incubation in the dark at RT, and the 
plates were read at 595 nm using a Victor 3 Multilabel Plate Reader (Perkin-Elmer). 
BrdU assay 
Cancer cells were treated with BMMSC-CM as indicated previously. Cell proliferation was 
measured using the BrdU Cell Proliferation Assay Kit (Cell Signalling Tech Inc) according to 
the manufacturer’s protocol. Plates were read at 450 nm using a Victor 3 Multilabel Plate 
Reader. 
Caspase-3 assay 
U87 cells were treated with BMMSC-CM as indicated previously. The activity of apoptosis-
inducing caspase-3 was assayed using the EnzChek DEVD-CHO Caspase3 Assay Kit 


































































correlated with an increase in caspase-3 activity. The fluorescence intensity was measured 
using a Victor 3 Multilabel Plate Reader at 485/535 nm (Ex/Em). 
Western blotting 
Protein expression levels of ß catenin, the downstream and central component of canonical 
Wnt signaling, was determined by Western blotting. After treatment of U87 cells with 
BMMSC-CM, total protein in each condition was isolated in RIPA buffer (Invitrogen) 
following the manufacturer’s instructions. Western blots contained 40 ug of protein per lane 
on a 8% Tris-glycine SDS-polyacrylamide gel. Proteins were transferred to a PVDF 
membrane (GE, NJ, USA). Blots were blocked in PBS containing 5% nonfat dry milk 
powder and incubated overnight at 4°C with either anti-human mouse ß-catenin mAbs 1:500 
dilution (R & D Systems, MN, USA), or anti- human mouse phospho ß-catenin mAbs 1:500 
dilution (R & D Systems, MN, USA) or anti-human mouse GAPDH mAbs 1:500 dilution 
(Millipore). Rabbit anti-mouse Horse Radish Peroxidase linked secondary antibodies (1: 
3000) were used to bind to the primary antibody. The blot was developed with enhanced 
chemiluminescence reagent (Pierce, IL) and images were captured using AlphaImager (CA, 
USA). 
Wound scratch assay: 
U87 cells were grown in 6-well plates at a density of 3 × 10
6
/mL, and a small linear scratch
was created in the confluent monolayer by gently scraping with a sterile cell scraper as per 
standard methods [19]. Cells were extensively rinsed with medium to remove cellular debris 
and treated with BMMSC-CM at passage 2. The area of the wound at selected time points (0, 
12, 24, and 48 hours) was recorded to assess migration and wound healing using a bright field 
phase contrast microscope (Nikon- Eclipse TE 2000-S) and photographs were taken using 


































































In vitro angiogenesis assay: 
The effect of BMMSC-CM on capillary tube formation of U87 cells was investigated using 
an In-vitro angiogenesis assay kit (Millipore, USA) according to the manufacturer’s 
instructions.  The formation of capillary tubes by the glioma cell line U87 in Matrigel has 
been previously demonstrated [20] .Briefly, 10000 cells/well were seeded on a ECMatrix gel 
pre-coated 96-well plate and treated with either control medium or BMMSC-CM. Before 
seeding, U87 cells were treated with either control medium or BMMSC-CM for 24h, and 
equal numbers of cells were added for both control and BMMSC-CM U87 cells. To study for 
the disruption of the capillary tubes, U87 cells were first directly seeded in the ECMatrix in 
control medium. After the formation of capillary tubes after 8h, medium was replenished 
either with control medium or BMMSC-CM. Capillary tube formation was quantified at 4, 8, 
12, and 24h by bright field phase contrast microscope (Nikon- Eclipse TE 2000-S) and 
photographs were taken using Qimaging- QICAM-fast 1394.  The experiments were repeated 
thrice. 
In vitro migration assay: 
Cell migration was analyzed using a Transwell Migration System (BD Biosciences). Briefly, 
U87 cells were plated into upper chambers (Transwells with 8.0 μm pore size) in normal U87 
culturing medium. The lower compartment of the chamber contained regular medium or 
BMMSC-CM. The chambers were cultured at 37°C in 5% CO2 for 12 hours. The filter 
membranes were removed and the cell migrated to the lower surface were fixed with 70% 
ethanol and stained with H&E and visualized under a phase contrast microscope. The 



































































Data represent mean and SE from experiments done in triplicate. Each experiment was 
repeated three times. A two-sided Student’s t test was used to determine the significance of 
any differences. For all statistical analyses, the level of significance was set at a probability of 
<0.05 (* p value < 0.05). 
RESULTS 
PRENATAL chBMMSCs PROLIFERATE RAPIDLY AND EXPRESS 
CHARACTERISTIC MSC MARKERS 
Primary cells isolated from the 13-14 day prenatal chick bone marrow adhered in large 
numbers and elongated after 12h, and formed rapidly dividing colony forming units (CFUs) 
within 48h (Fig 1a). Cells proliferated rapidly and doubled in their numbers from their initial 
seeding density within 24h (Fig 1b). After about 2 days the cells exhibited characteristic 
fibroblastic morphology and obtained 90% confluence. These cells were passaged up to P2 
and were then analyzed for characteristic MSC markers by immunofluorescence, flow 
cytometry, and semi-quantitative PCR. They were positive for CD 73, CD 90, CD 105, and 
vimentin, but negative for CD34 and CD45 (Fig 1c-e). 
ChBMMSCs ARE ABLE TO RAPIDLY DIFFERENTIATE INTO ECTODERMAL, 
MESODERMAL, AND ENDODERMAL LINEAGES 
Upon induction with the respective factors, chBMMSCs underwent differentiation into the 
MSC tri-lineage of adipocyte, chondrocyte, and osteocyte cell types within 24 h (Fig 2a, b, 
and c). These cells stained positively with oil red O stain for adipocytes (Fig 2a), saffranin 
orange for chondrocytes (Fig 2b), and silver stain for osteocytes (Fig 2c). Upon testing for 
differentiation into the non-mesenchymal lineages, they were found to efficiently 


































































Hepatic differentiation was confirmed by morphology (Fig 2d1) and the cells staining bright 
pink, showing positivity for Periodic Acid- Schiff (PAS) stain (Fig 2d2). Islet-like 
differentiation was determined morphologically by the appearance of islet-like clusters (Fig 
2e1), immunohistochemical staining for insulin receptor (IR) (Fig 2e2), and DTZ-specific 
crimson red staining (Fig 2e3). Undifferentiated chBMMSCs did not stain for IR (Fig 2e4), 
confirming the absence of islet cells in the native chBMMSCs. The endodermal lineage 
differentiation was achieved as early as 48 h. Ectodermal lineage development was confirmed 
by neuronal differentiation in which the cells obtained neuronal morphology with elongated 
axons (Fig 2f1) and stained positively for the neuronal marker ß-3 tubulin, as confirmed by 
immunohistochemistry (Fig 2f2). Undifferentiated chBMMSCs did not stain for ß-3 tubulin 
(Fig 2f3), confirming the absence of neuronal cells in the native chBMMSCs. Cardiac 
differentiation was confirmed by morphology (Fig 2g1), the presence of the early cardiac 
induction nuclear marker GATA4 (Fig 2g2), and the late cardiac structural marker, troponin I 
(Fig 2g3). Undifferentiated chBMMSCs did not stain for troponin I (Fig 2g4). Both neuronal 
and cardiac morphology was seen within 3 days of induction, indicating highly efficient 
plasticity of these MSCs. The ability to differentiate  into neuronal, cardiac, hepatocyte, and 
islet cell types was confirmed by RT-PCR ( Fig 2h) of specific markers; namely, glial 
fibrillary astrocyte protein (GFAP) for neuronal, α myosin heavy chain ( MHC) for cardiac, 
GATA4 for hepatocyte, and Isl1 for islet cell differentiation. 
chBMMSCs EXPRESS PLURIPOTENCY MARKERS 
The early embryonic markers were identified by the localization of embryonic stemness- 
related transcription factors such as Oct4 and Sox2 in the nucleus (Fig 3a1, 2 and b1, 2). The 
mRNA expression of pluripotent markers Oct4, Sox2, and Nanog along with the 


































































that these MSCs are primitive and have still retained their pluripotent properties. Normal 
human fibroblasts, used as a negative control, did not express any pluripotent markers (Fig 
3c3). In order to demonstrate the loss of pluripotency upon differentiation, we analyzed the 
expression of Oct4, Sox2, and Nanog, before and after differentiation to the adipogenic 
lineage. There was a clear loss of expression of these markers (Fig 3c4), confirming that 
these markers are only present in undifferentiated stem cells. 
BMMSC CONDITIONED MEDIA SUPPRESSES GROWTH OF GLIOMA AND 
HEAD AND NECK CANCER CELLS, PREVENTS CELL MIGRATION AND 
INHIBITS ANGIOGENESIS 
In this study, we report for the first time the ability of secreted factors from chBMMSC 
culture media to inhibit tumor cell proliferation, migration, and angiogenesis. Conditioned 
medium of chBMMSCs (BMMSC-CM) at passage 2 was able to inhibit 50% of the 
proliferation of the glioma cell line U87 as determined by MTT assay (Fig 4a). This 
inhibition was not seen when we used the conditioned media of normal human fibroblast cells 
or mouse embryonic fibroblasts (Fig 4b). This inhibitory effect was further confirmed using a 
BrdU assay, which indicated a marked reduction in newly synthesized DNA when U87 cells 
were grown in BMMSC-CM (Fig 4d). We wanted to investigate if the inhibition by 
BMMSC-CM could be seen in different tumor lines and tested its effects on the head and 
neck cancer line Hep2. Growth inhibition, studied by MTT and BrdU assays, was similar to 
that seen with U87 cells and, over a period of 48h, Hep2 cellular growth was completely 
arrested (Fig 4c and d). 
To analyze the action of this inhibition of BMMSC-CM, we examined the activity of 
apoptosis-inducing caspase 3, using a caspase-3 assay. Apoptosis was induced in U87 cells 


































































Further, to obtain insights into the inhibitory mechanisms, we utilized activators of the Wnt- 
ß-catenin pathway. Lithium chloride, an inhibitor of GSK-3ß kinase and agonist Wnt3a, both 
activators of ß-catenin, abolished the inhibition by BMMSC-CM. Using an antibody against 
sFRP4, a known antagonist of Wnt-Frizzled-related binding protein (Frb) [21], also increased 
proliferation of BMMSC-CM treated U87 cells ( Fig 4f). These results clearly suggest that 
the mode of inhibition is through the Wnt- ß-catenin pathway.  
Conditioned medium was seen to have classic anti-tumor activity as assessed by migration 
and angiogenesis assays. Migration of U87 cells, as assessed by a wound scratch assay, was 
inhibited by BMMSC-CM (Fig 5a-d). Even after 24 h, the wounded area was not covered 
when treated with chBMMSC conditioned medium (Fig 5c), and, after 48h, the cells started 
undergoing apoptosis (Fig 5d). To further confirm inhibition of migration by BMMSC-CM, a 
migration assay was performed using a transwell migration system. We observed a marked 
inhibition of migration of U87 cells across the membrane by BMMSC-CM (Fig 5e), as 
observed by reduced H&E staining of the membrane in BMMSC-CM treated wells in 
comparison to the control. Angiogenesis, the hallmark property of aggressive tumors, was 
studied using an in vitro angiogenesis assay (Fig 6a-e). The classic angiogenic ring formation 
by U87 cells was retarded by BMMSC-CM in which the cells formed clumps, even after 24h 
incubation on an angiogenesis promoting matrix (Fig 6e). Additionally, angiogenic rings 
formed by U87 cells within 8h were disrupted upon incubation with BMMSC-CM for 24h 
(Fig 6f), demonstrating a clear inhibition of capillary tubes, whereas control medium further 
enhanced the tube formation after 24h. 
 BMMSC CONDITIONED MEDIA INHIBITS GLIOMA CELLS ACTING 


































































Expression of apoptotic genes and genes downstream of the Wnt- ß-catenin TCF-LEF axis 
were studied. qPCR analysis of downstream activators of TCF-LEF linked to apoptosis and 
proliferation (Bax, caspase-3, xIAP, p21, and CyclinD1), metastasis (MMP2), and 
angiogenesis (VEGF) was performed. Apoptotic markers, p21, Bax, and caspase 3 were 
induced in BMMSC-CM treated U87 cells (Fig 7a, b), whereas expression of angiogenic 
gene (VEGF), ECM specific gene (MMP2), inhibitor of apoptosis gene (xIAP), and pro-
proliferation gene (CyclinD1) decreased (Fig 7a, b ).  A confirmatory role of ß-catenin being 
the target of inhibition by BMMSC-CM was provided by Western blot analysis, wherein ß 
catenin, although present in untreated U87 cells, was reduced in BMMSC-CM treated U87 
cells. In contrast, inactive phospho ß-catenin was only detected in BMMSC-CM treated U87 
cells, further confirming the role of ß-catenin in inhibition (Fig 7c). 
DISCUSSION 
In this study, we have characterized chicken BMMSCs for the first time in their embryonic 
stage, that is, from prenatal bone marrow. We show that these MSCs are extremely pliable 
and plastic, and have a very high turnover rate. Unlike MSCs isolated from adult human 
tissues, chBMMSCs were able to differentiate into all lineages of the ecto-, meso-, and 
endodermal types at a very rapid rate upon induction. Furthermore, we provide evidence that 
the media in which these MSCs are grown have a potent anti-tumorigenic effect by 
promoting apoptosis. This is the first time that MSCs from a non-mammalian organism have 
been shown to possess an anti-tumorigenic potential, indicating that stem cells have a 
property to detect and curb uncontrolled proliferation, and that this is probably a universal 
feature of mesenchymal stem cells. 
Bone marrow MSCs from the chick have been characterized initially from the 1-14 days old 


































































cells have been demonstrated to differentiate into bone and cartilage tissue when grown in a 
three-dimensional polymer scaffold [23]. However, a broad differentiation potential and a 
pluripotentiality of early chick embryo BMMSCs has not been demonstrated so far.  In our 
study, we have isolated BMMSCs from prenatal chicken and found them to have a very rapid 
turnover time of 24h, which identifies these as one of the fastest proliferating MSCs [24]. 
This could be attributed to their stage in very early development during the process of 
organogenesis, when a high turnover of stem cells is required to build the organs for 
completing development. On further characterization of these MSCs, we found them to be 
completely similar to human BMMSCs in relation to their marker profile and stemness 
properties. This suggests that chBMMSCs are an attractive source of MSCs in which 
isolation and proliferation is extremely rapid and can be obtained with minimum ethical 
constraints in comparison to human tissues. Additionally, we also demonstrated that 
chBMMSCs could differentiate into a wide variety of cell types in addition to the classic tri-
lineage of adipocyte, chondrocyte, and osteocyte cell types. These MSCs differentiated upon 
induction into all the lineages we tested; namely, neuronal, cardiac, hepatic, and islet-like 
cells. Their duration of induction was much shorter than previously reported for any MSCs, 
with most lineages showing the early differentiation markers within 3-4 days of induction. 
This extreme plasticity could be attributed to the early developmental stage from which they 
were obtained, a property which could be exploited for studying the molecular regulation of 
lineage differentiation using a short time span. Bone marrow derived MSCs are plastic 
entities equipped with the ability to adjust to new mircoenvironments. However, this ability is 
limited in the adult tissue and is mostly confined to differentiation into the classic tri-lineage 
of mesodermal types such as osteogenic, adipogenic, and chondrogenic [25]. The wide 
spectrum of differentiation ability exemplified by the embryonic BMMSC, which we 


































































respect to their plasticity. Furthermore, since these BMMSCs are obtained from an early 
developmental stage, they are still naïve to new environs and are not lineage imprinted as 
seen with mesenchymal stromal cells derived from adult tissues [26]. These chick BMMSCs 
could thus be used as an ideal model for testing developmental toxins affecting the 
differentiation process of neuronal, cardiac, and hepatic lineages.  
In chick BMMSCs isolated from early neonates, a pluripotent nature has been attributed to 
these MSCs [7]. This corroborates well with our study wherein we demonstrate the nuclear 
localization of Oct4 and Sox2, and mRNA expression of these markers, together with Nanog 
and CD44, and the loss of the pluripotent markers upon differentiation. The expression of 
pluripotency markers is probably related to the fetal or prenatal stage from which they are 
isolated and which bears resemblance to the embryonic stem cells. In contrast, adult 
BMMSCs of chicken, dermal-derived chicken MSCs, MSCs derived from chicken umbilical 
cord Wharton Jelly [20, 27], or human fibroblasts, as observed in our study, have not been 
shown to express pluripotency or embryonic markers. Pluripotent stem cells are capable of 
differentiating into all embryonic germ layers and pluripotentiality is characterized by the 
expression of key pluripotent markers Oct4, Sox2, and Nanog [28, 29]. These markers can be 
induced by reprogramming or can occur naturally as seen in embryonic stem cells (ESCs). 
The expression of key pluripotent genes in chick embryonic BMMSCs, as seen in our study, 
further strengthens the notion that these stem cells are similar to ESCs. Detailed comparative 
studies between chick embryo BMMSCs and chick ESCs will throw light on the degree of 
pluripotentiality of these two stem cell types.   
Some of the most attractive properties of MSCs are their inherent ability to track tumor cells 
[30] and their innate anti-neoplastic properties [31]. Our observation of the anti-tumor ability 


































































that are apoptotic to tumor cells. Thus, the chBMMSC secretome is enriched with anti-
proliferative, anti-migratory, and pro-apoptotic factors that act against tumors. This effect of 
MSCs isolated from prenatal chicks may be significant in the context of the 
microenvironment of the source of these MSCs. Tumors are not common in the early embryo, 
suggesting that the embryonic microenvironment, although containing actively proliferating 
and actively differentiating cells, is non-permissive for tumors. Joel et al., [32] have studied 
the behavior of human glioblastoma multiforme (GBM) cells in the embryonic tissue 
microenvironment of the chicken embryo. They found that glioma stem cells enriched from 
GBM exhibited reduced proliferation and survival, altered gene expression, and did not form 
tumors within the proliferative embryonic neural tissue. Following a recent report [33], in 
which the Wnt antagonist DKK1 was shown to inhibit the anti-tumor property of human 
MSCs, we explored the role of the Wnt-ß-catenin axis in the tumor inhibitory properties of 
chick BMMSC-CM. At the extracellular level of the Wnt-ß-catenin pathway, addition of the 
Wnt agonist Wnt 3a, an antibody to the Wnt antagonist sFRP4, and using lithium chloride, 
the inhibitor of GSK3-ß (required for the phosphorylation of the cytosolic activator of Wnt, 
i.e., ß-catenin) were able to abolish inhibition. Further, active ß-catenin was reduced and
inactive phospho ß-catenin was only observed in the BMMSC-CM-treated U87 cells. 
Addition of BMMSC-CM also led to the inhibition of the anti-apoptotic genes xIAP and 
cyclin D1, the angiogenic genes VEGF, the metastasis-associated gene MMP2, but resulted 
in upregulation of apoptotic genes, caspase-3, p21, and Bax. All these genes are associated 
downstream of the Wnt- ß-catenin pathway, thereby providing evidence that chick MSC-CM 
mediated anti-tumor activity could be regulated by Wnt pathway associated genes. Inhibition 
of angiogenesis of U87 cells by BMMSC-CM also showed clearly an innate tumor non-
permissive ability. In addition, we demonstrate a marked suppression of migration of U87 


































































tumor ability of chick BMMSC-CM.   Further confirmation of the anti-proliferative effect 
using a head and neck tumor cell line, suggests that BMMSC-CM inhibition could be 
effective across multiple types of tumors. 
Therefore, chBMMSCs isolated from prenatal bone marrow could also have an innate tumor 
non-permissive ability that is inhibitory to glioma cells, thereby preventing their proliferation 
and migration (as seen in the wound scratch assay), and resulting in an increase of apoptotic 
markers (p21 and Bax) and a decrease in the oncogenic marker, CycD1. 
Thus, from the observations in this study, we conclude that BMMSCs derived from prenatal 
chicken can be used as an easily available and rapidly proliferating stem cell platform to 
explore factors contributing to pluripotency, stemness, and regulation of multi-lineage 
differentiation. The anti-tumorigenic potential of the secreted factors from chBMMSCs needs 
to be further characterized to develop an effective therapeutic against glioblastoma. 
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Figure 1. Characterization of chBMMSCs 
a) Formation of colony forming units and crystal violet stain indicating a colony cluster.
The colonies appear as clumps of small fibroblastic cells.
b) Population doubling time was observed at 24h and the cells were actively proliferating
up to 5 days, after which there was growth inhibition. Results are the mean ± SD of two
independent experiments and in triplicates each (* p value <0.01, n=3).
c) Immunolocalization showing positive staining for CD 73 and vimentin.
d) RT-PCR of CD markers showing expression of MSC markers CD73, 90, and 105, and
absence of negative marker CD45.
e) Flow cytometry of CD markers showing CD 73 (96%), CD 90 (99%), and no expression
of CD 34.
Figure 2. Multilineage differentiation potential of chBMMSCs 
A) Differentiation to the adipocyte lineage was confirmed by staining with Oil red O. Clear
lipid secreting globules are seen.
B) and C)  Osteocyte differentiation by Von Kossa staining  and chondrocyte differentiation
by Alcian blue respectively.
D) Differentiation to hepatocyte lineage seen by morphology (D1) and PAS staining (D2).
E) Islet-like cells were observed by cluster-like morphology (e1) and by specific staining
for       insulin receptor (IR) using immunohistochemistry (E2), by DTZ staining (E3). Lack 
of islet cells was demonstrated in the undifferentiated MSCs by the absence of IR staining 
(E4). 
F) Neuronal differentiation was seen morphologically by visualization of the axonal
processes (F1) and by immunolocalization of the neuron specific marker ß-3 tubulin (F2). 
Lack of neuronal cells was demonstrated in the undifferentiated MSCs by the absence of ß-3 
tubulin staining (F3). 
G) Cardiomyocyte differentiation was observed by morphological changes such as cellular
spreading and formation of multiple junctions. Cardiac specific markers such as the 
cytoskeletal marker Troponin I (TnI in panel G2) and nuclear marker GATA4 (G3) were 
observed by immunolocalization using specific antibodies. Lack of cardiac cells was 
demonstrated in the undifferentiated MSCs by the absence of troponin I staining (G4). 
H) Expression of genes specific for islet cells (Isl1), hepatocyte (GATA4), neuronal cells
(GFAP), and mature cardiomyocytes (αMHC) were analysed by RT-PCR and showed 
positive expression in the respective differentiated samples. 
Figure
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Figure  3. Identification of pluripotent markers in chBMMSCs by immunolocalization and 
qPCR  
A) Staining of Oct 4 using phycoerythrin (magenta) labeled specific monoclonal antibodies
(A1) and nuclear localization of Oct4 observed by DAPI stain (A2).
B) Staining of Sox 2 using phycoerythrin (magenta) labeled specific monoclonal antibodies
(B1) and nuclear localization of Sox2 observed by DAPI stain (B2).
C) Quantitation of mRNA expression of pluripotent markers Sox2, Nanog, and Oct 4 and
MSC marker CD44 was observed by qPCR. Bar graph represents relative expression of these 
markers in comparison with GAPDH (c1).  Qualitative analysis of the pluripotent markers in 
chBMMSCs is represented in C2. Lack of expression of these markers is demonstrated in 
non-stem human fibroblast cells (C3). The high level of expression of the pluripotent markers 
in undifferentiated BMMSCs (U) is abolished upon adipocyte (A) differentiation (C4). 
Figure 4: Anti-tumorigenic potential of chBMMSC conditioned media 
A) Proliferation assay showed a clear reduction of U87 cell viability in chBMMSC
conditioned media (BMMSC-CM), with the highest inhibition seen in passage 2 cells.
B) Human fibroblast (HF) and mouse embryonic fibroblast (MEF) conditioned media (CM)
did not inhibit U87 cells. BMMSC-CM decreased proliferation progressively at 24h and
48h.
C) Proliferation assay showing that BMMSC-CM also inhibited proliferation of Hep2 cells
progressively at 24h and 48h.
D) BrdU assay demonstrated a sharp decrease in proliferating U87 cells and Hep2 cells.
E) Apoptotic assay using caspase-3/7 activity showed a clear increase in caspase activity
upon BMMSC-CM treatment of U87 cells. Dilution of BMMSC-CM decreased caspase
activity, and control CM (HF-CM and MEF-CM) showed no increase.
F) Wnt agonist Wnt3a, GSK3-ß inhibitor lithium chloride (LiCl), and anti-sFRP4 antibody
(antagonist of Wnt) increased proliferation of BMMSC-CM treated U87 cells.
Results are the mean ± SD of two independent experiments performed in triplicates (* p 
value 0.05, n=3). 
Figure  5. Wound scratch assay demonstrates the inhibition of proliferation of U87 cells by 
chBMMSC conditioned medium  
A) Wound was introduced at 0h in confluent U87 plates and treated with either control
medium or BMMSC- CM. Magnification is at 4X.
B) At 12h, the wound was partially covered in control whereas in BMMSC conditioned
medium treated cells there was no proliferation over the wound area. Magnification is at
10X.
C) At 24h, in control culture, the wound was fully covered, whereas there was limited
proliferation over the wound region in chBMMSC conditioned medium treated cells.
Magnification is at 10X.
D) At 48h, there was rapid proliferation in the untreated cells in contrast to chBMMSC
conditioned medium treated cells, where apoptosis of the cells was seen. Arrows indicate
cells that have undergone apoptosis. Magnification is at 10X.
E) H&E stain performed after an in vitro transwell migration assay indicated a marked
reduction of cell migration when U87 cells were incubated with chBMMSC conditioned
medium. Magnification is at 10X.
Figure 6. In vitro angiogenesis assay elucidates an anti-angiogenic effect of chBMMSC-CM 
A) U87 cells (treated for 24h with control or BMMSC-CM) were seeded at 0h on a pro-
angiogenic ECMatrix gel pre-coated plate and either control medium or BMMSC-CM
was added. Magnification is at 20X.
B) and C) At 4h and 8h, cells incubated in normal medium alone displayed initial processes
and tube formation whereas BMMSC-CM treated cells did not proliferate. Magnification
is at 20X.
D) At 12h, capillary tube formation was complete (indicated by arrows) in cells treated with
control medium. Growth was sparse in BMMSC-CM treated cells. Magnification is at 20X. 
E) At 24h, ring formation of the capillary tubes was prominent in control treated cells (as
indicated by arrows) in contrast to BMMSC-CM treated U87 cells in which cells clumped 
and proliferation was retarded. Magnification is at 10X for control medium-treated cells and 
at 20X for BMMSC-CM treated cells. 
F) Capillary tube formation of U87 cells was induced for 8h in control medium (upper and
lower left panels). Subsequent incubation with BMMSC-CM or control medium showed a 
complete disruption of the capillary tubes in BMMSC-CM (lower right panel) in contrast to 
the control medium, where the capillary tubes were strengthened (upper right panel).  
Figure 7. Expression analysis of Wnt-specific and apoptotic markers by qPCR and 
Western blotting 
A) and B) Expression of pro-proliferative and pro-angiogenic markers downstream of Wnt,
namely VEGF, MMP2, Cyclin D1, and xIAP was reduced and expression of apoptotic
markers such as caspase-3, Bax, and p21 was increased in BMMSC-CM treated cells as 
shown by qPCR (b) and qualitative analysis of these markers.  
C) Western blot analysis showed reduced ß-catenin protein levels in U87 cells treated with
BMMSC-CM. Phospho ß-catenin was detected only in U87 cells treated with BMMSC-CM. 
Table 1: Primer sequences for pluripotency, MSCs, and differentiation 







F: 5’ATGGCATCCAAGGAGTGA 3’ 




F -5’TCC GGC GGT AAT AAT AGC AG 3’ 









F -5’CAG CAG ACC TCT CCT TGA CC3’ 




F- 5’TCAGTGAGAGTGGGGAGAGG 3’  





























F -5’TCAGGAGTTGTCAAGGCAGAG3’       
R  -5’TCCGGGCTGTTTTTCTGGTT3’    
55 520 
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Human 
Nanog 
F  - 5’CCTCCTCCATGGATCTGCTTATTCA3’ 




F  -5’AGGGCAAGCGATCAAGCA3’ 




F  -5’TTCCGCAAGATCCAGCATGA  3’ 




F  -5’GTCTCCAGCCACTCCATCTG 3’ 




F  -5’GAGATGGCCCGCCACTTGCG 3’ 




F  -5’ TGATGAAGCAACTCCAGCAG 3’ 
R – 5’ GGACTGGCTACCATGCTGTT 3’ 
50 214 
Table 2. Primer sequences for apoptotic markers- Human 





Bax F-5’ GCTGGACATTGGACTTCCTC 3’ 
R-5’ TCAGCCCATCTTCTTCCAGA 3’ 
247 61 
Cyclin D1 F-5’ AACTACCTGGACCGCTTCCT 3’ 
R-5’ CCACTTGAGCTTGTTCACCA 3’ 
187 61 
p21 F-5’ GAGGCCGGGATGAGTTGGGAGGAG 3’ 
R-5’ CAGCCGGCGTTTGGAGTGGTAGAA 3’ 
220 63 
GAPDH F-5’ CAGAACATCATCCCTGCATCCACT 3’ 
R-5’ GTTGCTGTTGAAGTCACAGGAGAC 3’ 
181 61 
Caspase 3 F-5’AAGGATCCTTAATAAAGGTATCCATGGAGAACACT3’ 
R-5’AAAGAATTCCATCACGCATCAATTCCACAATTTCTT3’ 
322 55 
MMP2 F- 5’CTCTCCTGACATTGACCTTGGCAC 3’ 
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